With the US privacy landscape more fragmented and active than ever and federal legislation stalled, lawyers at Sheppard Mullin explain how states are taking bold steps to define their own regimes By ...
This year’s most-read stories covered uncertainty at the USPTO, a potential boycott of a major international IP conference, rankings releases, and a contempt of court proceeding ...
The parties have agreed on a court-guided settlement covering Pantech’s entire SEP portfolio, marking a global first ...
The introduction of Canada’s patent term adjustment has left practitioners sceptical about its value, with high fees and limited eligibility meaning SMEs could lose out ...
On a professional level, Hurtado Rivas continues to receive accolades. In April, she was named ‘Europe In-House Leader of the Year (Soft IP)’ at the Managing IP Awards EMEA 2025. In November, she took ...
USPTO director John Squires is recognised for his policy changes to inter partes review and post-grant review proceedings. Although Squires has only recently been named director, he has made ...
Hoglund, who announced yesterday, December 15, that he is to leave Via at the end of 2025, is set to reveal his new venture in the new year.
Eugene Ho, who won the 'Asia-Pacific In-House IP Leader of the Year' award in 2025, has also won several accolades over the years for his instrumental role in shaping the IP strategy and portfolio of ...
The new court has drastically changed the German legal market, and the Munich-based firm, with two recent partner hires, is among those responding ...
Proactive measures are needed to counteract opportunistic bad-faith actors, say Diep Thi Bich Le and Hang Thi Thanh Phan of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins One ...
In this episode, sponsored by Zacco, we delve into Online IP Protection and how the concept of protecting brands online is evolving. Many of you will have heard of Online Brand Protection, a service ...
Koen Bijvank of Brinkhof and Johannes Heselberger of Bardehle Pagenberg discuss the Amgen v Sanofi case and why it will be cited frequently Amgen successfully defended its European patent (EP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results